Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Molecular Sciences
|
December 4, 2012
Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model
Irene Appolloni, Sebastiano Curreli, Sara Caviglia, et al.
Cancer Letters
|
November 17, 2019
Glioblastoma models driven by different mutations converge to the proneural subtype
Francesco Alessandrini, Davide Ceresa, Irene Appolloni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 23, 2012
Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma
Eleonora Gambini, Elisa Reisoli, Irene Appolloni, et al.
Cancer Letters
|
October 13, 2018
Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
Irene Appolloni, Francesco Alessandrini, Davide Ceresa, et al.
Oncogene
|
February 14, 2019
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
Francesco Alessandrini, Laura Menotti, Elisa Avitabile, et al.
Journal for Immunotherapy of Cancer
|
January 16, 2026
Therapeutic vaccination for glioblastoma elicited by retargeted oncolytic herpes virus
Francesca Piaggio, Chiara Riviera, Francesco Alessandrini, et al.
Viruses
|
September 28, 2021
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
Irene Appolloni, Francesco Alessandrini, Laura Menotti, et al.
Biochimica Et Biophysica Acta. General Subjects
|
December 12, 2018
TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways
Santina Venuto, Stefano Castellana, Maria Monti, et al.
Cancer Cell
|
August 4, 2023
Early clonal extinction in glioblastoma progression revealed by genetic barcoding
Davide Ceresa, Francesco Alessandrini, Sara Lucchini, et al.
Cancer Research
|
March 7, 2014
Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma
Rebecca Favaro, Irene Appolloni, Serena Pellegatta, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Molecular Sciences
|
December 4, 2012
Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model
Irene Appolloni, Sebastiano Curreli, Sara Caviglia, et al.
Cancer Letters
|
November 17, 2019
Glioblastoma models driven by different mutations converge to the proneural subtype
Francesco Alessandrini, Davide Ceresa, Irene Appolloni, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 23, 2012
Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma
Eleonora Gambini, Elisa Reisoli, Irene Appolloni, et al.
Cancer Letters
|
October 13, 2018
Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
Irene Appolloni, Francesco Alessandrini, Davide Ceresa, et al.
Oncogene
|
February 14, 2019
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
Francesco Alessandrini, Laura Menotti, Elisa Avitabile, et al.
Journal for Immunotherapy of Cancer
|
January 16, 2026
Therapeutic vaccination for glioblastoma elicited by retargeted oncolytic herpes virus
Francesca Piaggio, Chiara Riviera, Francesco Alessandrini, et al.
Viruses
|
September 28, 2021
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
Irene Appolloni, Francesco Alessandrini, Laura Menotti, et al.
Biochimica Et Biophysica Acta. General Subjects
|
December 12, 2018
TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways
Santina Venuto, Stefano Castellana, Maria Monti, et al.
Cancer Cell
|
August 4, 2023
Early clonal extinction in glioblastoma progression revealed by genetic barcoding
Davide Ceresa, Francesco Alessandrini, Sara Lucchini, et al.
Cancer Research
|
March 7, 2014
Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma
Rebecca Favaro, Irene Appolloni, Serena Pellegatta, et al.
Page
of 3